Ledger.Open graph →
SEC Form D · filed August 15, 2019

Limelight Bio, Inc

Offering
$50.0M
Sold
$14.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Philip R. Johnson · Philadelphia, PAExec · DirectorNelson C. Chu · Chevy Chase, MDExec · DirectorSeth L. Harrison · New York, NYDirectorDavid L. Shin · Philadelphia, PAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗